Home › Chronic Kidney Disease › Texas › Arlington
Chronic Kidney Disease clinical trials in Arlington, TX
4 studies for Chronic Kidney Disease are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
RecruitingPhase 2
- Investigator Site #5, Arlington
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
RecruitingPhase 3
- Research Site, Arlington
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
RecruitingPhase 2
- Arlington Nephrology, PLLC., Arlington
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
RecruitingPhase 3
- Research Site, Arlington
About Chronic Kidney Disease
If your kidneys are damaged and can't filter blood easily, then you may suffer from chronic kidney disease (CKD). Read about the treatments available
More about Chronic Kidney Disease on MedlinePlus
Chronic Kidney Disease trials in other cities
- New York City, NY16 studies
- Boston, MA15 studies
- Philadelphia, PA15 studies
- Dallas, TX15 studies
- Houston, TX15 studies
- Chicago, IL12 studies
- Orlando, FL11 studies
- Atlanta, GA10 studies
- Kansas City, MO9 studies
- Durham, NC9 studies
- San Antonio, TX8 studies
- Washington, DC8 studies
Other studies in Arlington
- Steatotic Liver Disease6 studies
- Crohn's Disease5 studies
- Lupus4 studies
- Atopic Dermatitis (Eczema)4 studies
- Non-Small Cell Lung Cancer4 studies
- Sjogren's Syndrome4 studies
- Ulcerative Colitis4 studies
- Psoriatic Arthritis4 studies
- Rheumatoid Arthritis4 studies
- High Blood Pressure3 studies
- Overactive Bladder3 studies
- Breast Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.